T. Rowe Price Associates’s Exscientia Plc American Depositary Shares EXAI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-853,156
Closed -$4.55M 2959
2022
Q4
$4.55M Sell
853,156
-11,765
-1% -$74.3K ﹤0.01% 1211
2022
Q3
$7.1M Sell
864,921
-5,723
-0.7% -$57.7K ﹤0.01% 1132
2022
Q2
$9.48M Sell
870,644
-25,332
-3% -$302K ﹤0.01% 1326
2022
Q1
$12.9M Buy
895,976
+14,898
+2% +$254K ﹤0.01% 1330
2021
Q4
$17.4M Buy
+881,078
New +$18.5M ﹤0.01% 1313

Other funds holding EXAI

T. Rowe Price Associates's EXAI Position: Q1 2023 in Review

T. Rowe Price Associates sold out of Exscientia Plc American Depositary Shares (EXAI) in Q1 2023, closing a stake of 853,156 shares — an estimated $4.55M sold.

T. Rowe Price Associates first reported a position in EXAI in Q4 2021 and held it in 5 quarters. The position peaked at $17.4M in Q4 2021. 58 funds tracked by Wall St. Rank hold EXAI as of Q1 2023.

  • T. Rowe Price Associates reported no remaining Exscientia Plc American Depositary Shares position as of Q1 2023 after selling out during the quarter.
  • T. Rowe Price Associates sold 853,156 Exscientia Plc American Depositary Shares shares in Q1 2023, an estimated $4.55M.
  • T. Rowe Price Associates first reported a position in Exscientia Plc American Depositary Shares in Q4 2021 and held it in 5 quarters.
  • T. Rowe Price Associates's Exscientia Plc American Depositary Shares position peaked at $17.4M in Q4 2021.
  • 58 funds tracked by Wall St. Rank held Exscientia Plc American Depositary Shares as of Q1 2023.

Based on T. Rowe Price Associates's 13F filing for Q1 2023, filed 15 May 2023.